We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+20.26%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$855M
AUM Growth
-$11.1M
Cap. Flow
-$107M
Cap. Flow %
-12.49%
Top 10 Hldgs %
7.94%
Holding
444
New
121
Increased
37
Reduced
148
Closed
134

Sector Composition

Rank Sector Weight
1 Healthcare 27.83%
2 Technology 22.35%
3 Consumer Discretionary 13.53%
4 Industrials 10.11%
5 Financials 3.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PGNX
26
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$5.01M 0.59%
671,331
+155,042
+30% +$938K
BOOT icon
27
Boot Barn
BOOT
$4.58B
$4.98M 0.58%
+155,707
New +$4.07M
BLOX
28
DELISTED
Infoblox Inc
BLOX
$4.95M 0.58%
188,843
-10,330
-5% -$261K
AGEN
29
Agenus
AGEN
$276M
$4.9M 0.57%
28,925
-2,738
-9% -$389K
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.87M 0.57%
152,389
+106,257
+230% +$2.69M
TREE icon
31
LendingTree
TREE
$551M
$4.86M 0.57%
61,848
-30,900
-33% -$1.9M
FRSH
32
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$4.81M 0.56%
232,004
-834
-0.4% -$15.3K
AMAG
33
DELISTED
AMAG Pharmaceuticals
AMAG
$4.79M 0.56%
69,434
-4,279
-6% -$269K
MMSI icon
34
Merit Medical Systems
MMSI
$4.82B
$4.76M 0.56%
220,807
+158,245
+253% +$3.21M
PFNX
35
DELISTED
Pfenex Inc.
PFNX
$4.75M 0.56%
244,945
+36,822
+18% +$617K
ATRC icon
36
AtriCure
ATRC
$2.08B
$4.74M 0.55%
192,352
+41,166
+27% +$919K
XENT
37
DELISTED
Intersect ENT, Inc
XENT
$4.69M 0.55%
163,914
+111,009
+210% +$2.91M
GIII icon
38
G-III Apparel Group
GIII
$1.54B
$4.67M 0.55%
66,442
-5,288
-7% -$324K
SUPN icon
39
Supernus Pharmaceuticals
SUPN
$2.7B
$4.64M 0.54%
+273,517
New +$3.89M
GTT
40
DELISTED
GTT Communications, Inc.
GTT
$4.58M 0.54%
192,039
-57,015
-23% -$1.16M
TACO
41
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$4.55M 0.53%
+299,102
New +$4.54M
SAGE
42
DELISTED
Sage Therapeutics
SAGE
$4.55M 0.53%
+62,313
New +$4.01M
GLIN icon
43
VanEck India Growth Leaders ETF
GLIN
$94.9M
$4.54M 0.53%
107,146
+1,493
+1% +$66.5K
CPE
44
DELISTED
Callon Petroleum Company
CPE
$4.53M 0.53%
54,421
+9,610
+21% +$798K
NVAX icon
45
Novavax
NVAX
$1.21B
$4.52M 0.53%
20,292
-6,872
-25% -$1.21M
TTPH
46
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$4.47M 0.52%
4,716
-1,510
-24% -$1.23M
SRNE
47
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$4.39M 0.51%
+249,028
New +$3.2M
ASNA
48
DELISTED
Ascena Retail Group, Inc.
ASNA
$4.39M 0.51%
+13,173
New +$4.03M
ACHC icon
49
Acadia Healthcare
ACHC
$2.52B
$4.38M 0.51%
55,898
+6,244
+13% +$449K
IMPV
50
DELISTED
Imperva, Inc.
IMPV
$4.34M 0.51%
+64,116
New +$3.54M

Similar funds

EAM Investors's Q2 2015 Portfolio in Review

As of Q2 2015, EAM Investors held 444 positions worth $855M, down 1.3% from $866M the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

EAM Investors withdrew a net $107M in Q2 2015, closing 134 positions and reducing 148 holdings. Its most notable exit was Esperion Therapeutics, an estimated $8.27M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Echo Global Logistics, Inc. worth $5.1M.

  • EAM Investors's largest Q2 2015 buy was Echo Global Logistics, Inc.: 156,173 shares worth $5.1M.
  • EAM Investors added most to Paycom in Q2 2015, an estimated $4.06M increase.
  • EAM Investors's biggest Q2 2015 reduction was Eagle Pharmaceuticals, Inc., cutting an estimated $5.02M.
  • EAM Investors fully exited Esperion Therapeutics in Q2 2015, selling an estimated $8.27M.
  • EAM Investors's ten largest holdings make up 7.9% of its $855M portfolio in Q2 2015.
  • EAM Investors opened 121 new positions and closed 134 in Q2 2015.
  • EAM Investors's portfolio value fell 1.3% quarter-over-quarter to $855M.

Based on EAM Investors's 13F filing for Q2 2015, filed 13 Aug 2015.